In Support of Magnani and Taylor
- PMID: 38157868
- PMCID: PMC11749498
- DOI: 10.5858/arpa.2023-0446-LE
In Support of Magnani and Taylor
Conflict of interest statement
Bogen is an officer and shareholder in Boston Cell Standards. The other authors have no relevant financial interest in the products or companies described in this article.
Comment on
-
Immunohistochemistry Should Be Regulated as an Assay.Arch Pathol Lab Med. 2023 Nov 1;147(11):1229-1231. doi: 10.5858/arpa.2023-0048-ED. Arch Pathol Lab Med. 2023. PMID: 37493520 No abstract available.
References
-
- Magnani B, Taylor CR. Immunohistochemistry should be regulated as an assay. Arch Pathol Lab Med. 2023;147(11):1229–1231. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
